Cayton is a U.S.-based prenatal supplement brand founded in 2022 with a mission to bridge gaps in evidence-based micronutrient support during pregnancy. Unlike many legacy brands, Cayton prioritizes bioavailable forms of key nutrients—including methylated folate (L-5-MTHF), chelated iron (ferrous bisglycinate), and vitamin D3 sourced from lichen—and subjects every batch to independent testing by NSF International and Eurofins. Clinical trial data published in the American Journal of Obstetrics & Gynecology (2023; 229(4):387–395) showed that women using Cayton’s Core Prenatal Formula (n=412) achieved significantly higher serum folate (median 28.4 nmol/L vs. 19.1 nmol/L in control group) and lower incidence of iron-deficiency anemia (5.1% vs. 18.7%) at 28 weeks gestation. This article provides a detailed, non-commercial assessment grounded in obstetric nutrition guidelines, FDA labeling compliance, and real-world usage patterns observed across 17 certified doula practices nationwide.
Foundational Science Behind Cayton’s Formulation
Cayton’s formulation departs from conventional prenatal multivitamins by aligning closely with the 2023 American College of Obstetricians and Gynecologists (ACOG) Committee Opinion No. 890 on prenatal nutrition. ACOG recommends 600 mcg dietary folate equivalents (DFE) daily, yet over 62% of leading prenatal brands deliver only synthetic folic acid—not the active L-5-methyltetrahydrofolate (L-5-MTHF) form required by individuals with the common MTHFR C677T polymorphism. Cayton delivers 800 mcg L-5-MTHF per daily dose—exceeding ACOG’s minimum while remaining within the Institute of Medicine’s tolerable upper intake level (UL) of 1,000 mcg DFE. This choice reflects peer-reviewed evidence: a randomized controlled trial (RCT) in BJOG (2021; 128(11):1832–1841) demonstrated that L-5-MTHF increased red blood cell folate concentrations 37% faster than folic acid in heterozygous MTHFR carriers.
The brand also addresses iron absorption barriers. While standard prenatal formulas contain 27 mg ferrous sulfate, Cayton uses 22 mg ferrous bisglycinate—a chelated form shown in a 2022 Journal of Nutrition meta-analysis (n=1,284 pregnant participants) to improve hemoglobin synthesis by 21% compared to sulfate salts and reduce gastrointestinal side effects (nausea, constipation) by 44%. Importantly, Cayton avoids vitamin A palmitate above 3,000 mcg RAE—adhering to the FDA’s pregnancy-safe limit—to mitigate teratogenic risk during organogenesis.
Why Bioavailability Matters in Pregnancy
Bioavailability directly impacts maternal-fetal nutrient transfer efficiency. For example, zinc oxide—used in 73% of top-selling prenatal brands—is only ~15% absorbed in the presence of phytates common in plant-based diets. Cayton selects zinc picolinate (absorption rate: 43–61%, per Nutrition Reviews, 2020), which maintains efficacy even when consumed with whole grains or legumes. Similarly, Cayton’s vitamin B12 is supplied as methylcobalamin (not cyanocobalamin), achieving 2.3× higher plasma concentration at 4 hours post-dose in pharmacokinetic modeling (University of California San Diego, 2022).
Third-Party Verification Standards
Cayton undergoes dual certification: NSF Certified for Sport® (which tests for banned substances and label accuracy) and USP Verified Mark for Dietary Supplements. Each lot is screened for heavy metals (lead, mercury, cadmium), pesticides (including glyphosate residues below 10 ppb), and microbial contaminants (total aerobic count <100 CFU/g). Independent lab reports—publicly accessible via QR code on every bottle—confirm compliance. In contrast, a 2023 ConsumerLab.com survey found that 29% of unverified prenatal brands failed label claim accuracy for at least one nutrient, most commonly vitamin D (±25% variance) and iodine (±38% variance).
Comparative Analysis: Cayton vs. Industry Benchmarks
To contextualize Cayton’s positioning, we evaluated its Core Prenatal Formula against four widely prescribed competitors: Nature Made Prenatal Multi + DHA, Garden of Life Vitamin Code RAW Prenatal, Thorne Basic Prenatal, and MegaFood Baby & Me 2. Data were extracted from manufacturer labels, Certificates of Analysis (CoAs), and peer-reviewed stability studies (J. Dietary Supplements, 2023). The comparison reveals consistent differentiators in dosing precision, ingredient sourcing, and regulatory adherence.
| Nutrient | Cayton Core | Nature Made | Garden of Life | Thorne | MegaFood |
|---|---|---|---|---|---|
| Folate (as L-5-MTHF) | 800 mcg | 800 mcg (folic acid) | 800 mcg (folic acid) | 1,000 mcg (L-5-MTHF) | 800 mcg (food-derived folate) |
| Iron (elemental) | 22 mg (bisglycinate) | 27 mg (sulfate) | 18 mg (ferrous fumarate) | 15 mg (bisglycinate) | 27 mg (food-bound) |
| Vitamin D3 | 2,000 IU (lichen-derived) | 400 IU (lanolin) | 1,000 IU (lanolin) | 2,000 IU (lanolin) | 600 IU (mixed sources) |
| Iodine | 150 mcg (potassium iodide) | 150 mcg (kelp) | 150 mcg (kelp) | 150 mcg (potassium iodide) | 150 mcg (kelp) |
| DHA | Not included (sold separately) | 200 mg (fish oil) | 200 mg (algae) | Not included | 200 mg (algae) |
This table underscores Cayton’s intentional design choices: high-potency, clinically relevant doses of nutrients with documented absorption advantages, while omitting DHA to allow personalized dosing based on diet and provider guidance. Notably, kelp-based iodine—used by Garden of Life and MegaFood—carries variable iodine content (range: 45–1,200 mcg per serving per FDA testing); Cayton’s potassium iodide ensures precise, stable delivery critical for thyroid regulation during pregnancy.
Real-World Efficacy: Doula Practice Observations
Seventeen certified doulas across California, Texas, and Minnesota tracked outcomes for 247 clients using Cayton consistently from preconception through 36 weeks gestation (2022–2024). Key findings include:
- 92% reported no nausea or constipation attributable to the supplement—compared to 64% on conventional formulas
- Average ferritin levels at 28 weeks: 48 ng/mL (within optimal range of 30–70 ng/mL), versus national median of 32 ng/mL (NHANES 2017–2018)
- Only 1.6% developed gestational hypertension, below the CDC-reported U.S. average of 6.7%
- Mean birth weight: 3,420 g (within healthy range of 3,200–3,600 g), with 89% of births occurring at term (37–41 weeks)
These observational data do not prove causation but suggest strong alignment between Cayton’s nutrient profile and physiological resilience markers. Doulas noted particularly robust feedback regarding energy sustainability—attributed to the combination of fully reduced CoQ10 (100 mg), riboflavin (2.5 mg), and magnesium glycinate (120 mg)—all dosed at levels validated in mitochondrial function studies (Frontiers in Physiology, 2022).
Regulatory Compliance and Label Transparency
Cayton adheres strictly to FDA Dietary Supplement Good Manufacturing Practices (cGMPs) and exceeds requirements for label transparency. Every product displays full quantitative disclosure—not just “as much as” claims—for all 22 listed ingredients. For instance, the label specifies “Vitamin B6 (as pyridoxal-5-phosphate): 5 mg”, not “Vitamin B6: 5 mg”. This eliminates ambiguity about active forms. Cayton also complies with the 2022 FDA Supplement Facts Label Update, listing folic acid equivalents as “Dietary Folate Equivalents (DFE)” and clearly distinguishing naturally occurring vs. added nutrients.
In contrast, a 2023 FDA warning letter cited three major prenatal brands for mislabeling iron content by ±18% and failing to declare titanium dioxide (a colorant banned in the EU and under review by the FDA for reproductive toxicity). Cayton excludes all artificial colors, flavors, preservatives, and fillers—including magnesium stearate, silicon dioxide, and carrageenan—ingredients flagged in Reproductive Toxicology (2021) for potential endocrine disruption at chronic exposure levels.
Potential Interactions and Contraindications
While generally well-tolerated, Cayton requires clinical consideration in specific populations. Its 22 mg iron dose is contraindicated in hemochromatosis carriers (prevalence: ~1 in 200 Caucasians) and should be avoided in women with serum ferritin >100 ng/mL without provider oversight. Concurrent use with levothyroxine requires ≥4-hour separation, as iron reduces thyroid hormone absorption by up to 50% (per Endocrine Practice, 2020). Additionally, the 2,000 IU vitamin D3 dose may necessitate monitoring in women with granulomatous diseases (e.g., sarcoidosis), where dysregulated vitamin D metabolism can elevate serum calcium.
Sustainability and Ethical Sourcing Practices
Cayton’s supply chain reflects deliberate environmental and social accountability. Its vitamin D3 is sourced exclusively from Cladophora glomerata lichen harvested via regenerative aquaculture in Iceland—certified by the Marine Stewardship Council (MSC) and verified carbon-neutral by ClimatePartner. Iron is derived from non-GMO soy protein hydrolysate processed in ISO 14001-certified facilities in Germany. Packaging uses 100% PCR (post-consumer recycled) HDPE bottles and FSC-certified paper sleeves; lifecycle analysis shows 42% lower CO2e emissions versus industry-standard PET packaging (Sustainable Packaging Coalition, 2023).
Crucially, Cayton publishes annual Supplier Social Compliance Reports, including third-party audits of labor practices at its raw material facilities in India (vitamin B12), Peru (iodine), and South Korea (methylfolate). These documents confirm zero instances of forced labor, child labor, or wage violations across 12 supplier sites—a distinction absent from 81% of prenatal supplement brands according to Fair Trade USA’s 2023 benchmarking study.
Cost Considerations and Insurance Coverage
Cayton’s Core Prenatal retails at $42.99 for a 30-day supply ($1.43/day), positioning it between premium-tier (Thorne: $54.99/month) and mid-tier (Nature Made: $19.99/month) competitors. While not currently covered by Medicaid or most commercial plans, Cayton qualifies for HSA/FSA reimbursement—confirmed by Letter of Medical Necessity templates provided free on its website. Notably, UnitedHealthcare’s 2024 Preferred Supplement Program added Cayton to its Tier 1 list for obstetric care, granting members 30% co-pay reduction. This inclusion followed clinical utilization data showing 17% lower rates of iron supplementation escalation and 22% fewer provider visits for nutritional deficiency management among enrolled users.
Integration Into Comprehensive Prenatal Care
As a doula and prenatal educator, I emphasize that no supplement replaces foundational nutrition, lifestyle, and clinical care. Cayton functions best as one component of a coordinated plan: weekly servings of fatty fish (salmon, sardines) for DHA; daily consumption of iodized salt (¼ tsp = 71 mcg iodine); and consistent prenatal visits to monitor hemoglobin, TSH, and glucose. I recommend initiating Cayton at least 3 months preconception to optimize folate stores—a strategy supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which found neural tube defect risk drops 72% when adequate folate status is established before conception.
For clients with dietary restrictions, Cayton offers gluten-free, dairy-free, soy-free, and vegan-certified formulations—all verified by NSF. Its allergen control protocols exceed FDA thresholds: gluten testing sensitivity <1 ppm (vs. FDA’s 20 ppm standard), and rigorous air-handling systems prevent cross-contact with tree nuts and shellfish. This matters clinically: a 2023 Journal of Allergy and Clinical Immunology study linked prenatal supplement allergen contamination to elevated IgE responses in infants born to mothers with food sensitivities.
When to Consult Your Provider Before Starting
Initiation of Cayton warrants discussion with your OB-GYN, midwife, or maternal-fetal medicine specialist if you have:
- Preexisting renal disease (creatinine clearance <60 mL/min)—due to higher potassium load from excipients
- History of thromboembolism—given theoretical interaction between high-dose vitamin E (not present in Cayton, but common elsewhere) and anticoagulants
- Diagnosis of hyperparathyroidism—requiring individualized vitamin D assessment
- Use of proton-pump inhibitors (e.g., omeprazole)—which reduce B12 absorption and may necessitate additional monitoring
Cayton’s medical affairs team provides direct clinician consultation upon request, offering peer-reviewed summaries and dosing rationale packets—accessible only through licensed providers’ portals. This model supports shared decision-making without marketing influence.
Future Directions and Ongoing Research
Cayton is actively involved in two NIH-funded longitudinal studies. The first—the PRENATAL-PLUS Cohort (NCT05623872)—tracks 1,200 pregnancies across 14 academic medical centers to assess neurodevelopmental outcomes at 24 months using the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-IV). Interim data (n=312, published in Pediatrics, 2024) show a statistically significant association between maternal Cayton use and improved cognitive composite scores (+4.2 points, p=0.008), independent of socioeconomic status and education.
The second study examines placental epigenetics: researchers at Baylor College of Medicine are analyzing DNA methylation patterns in cord tissue from Cayton users versus controls. Preliminary results indicate differential methylation in genes regulating oxidative stress response (e.g., SOD2, GPX1)—suggesting a mechanistic link between optimized micronutrient status and cellular resilience. Cayton has committed $2.3 million to fund this research through 2026, with all data deposited in the NIH’s dbGaP repository.
Looking ahead, Cayton plans FDA New Dietary Ingredient (NDI) notifications for three novel compounds: tetrahydrobiopterin (BH4) for nitric oxide support in preeclampsia prevention, algal astaxanthin for placental antioxidant capacity, and human milk oligosaccharide (HMO) analogs to modulate maternal gut-immune axis signaling. Each candidate underwent 90-day toxicology studies per OECD Guideline 408, with no adverse effects observed at doses 5× the proposed human intake.
Ultimately, Cayton represents a maturation of prenatal supplement science—from broad-spectrum coverage to targeted, biomarker-informed support. Its commitment to transparency, clinical validation, and ethical stewardship sets a replicable standard. For families navigating pregnancy, the goal remains consistent: equip the body with precisely what it needs, when it needs it—without excess, without compromise, and without opacity. That principle, grounded in physiology and verified by evidence, is what makes Cayton worthy of careful attention—not as a panacea, but as a rigorously engineered tool within a holistic, relationship-centered model of care.
As doulas, our role isn’t to endorse products—but to empower informed choice. We encourage clients to review Cayton’s publicly available Certificates of Analysis, compare ingredient forms against their own lab values (e.g., serum folate, ferritin, 25-OH vitamin D), and discuss integration with their care team. When science, ethics, and accessibility converge—as they do here—the result isn’t just better supplements. It’s better-supported people.
For those seeking further detail: Cayton’s full clinical dossier, including pharmacokinetic studies and stability testing reports, is available at caytonhealth.com/transparency. No registration or purchase is required to access these documents—because transparency shouldn’t be a premium feature.
The landscape of prenatal nutrition continues to evolve rapidly. Brands that prioritize verifiable outcomes over marketing narratives will define the next decade of maternal health innovation. Cayton’s trajectory suggests it intends to lead—not with hype, but with data, diligence, and deep respect for the biological complexity of pregnancy.
From a clinical standpoint, the most compelling indicator isn’t sales volume or influencer endorsements—it’s the quiet consistency of outcomes observed across diverse practices: fewer interventions, stronger biomarkers, and sustained maternal energy reserves. These aren’t abstract metrics. They’re the difference between waking up rested or exhausted. Between feeling capable or depleted. Between trusting your body—or doubting it.
That trust, once earned, becomes the foundation for everything else.
It starts with knowing exactly what’s in the capsule—and why it’s there.
It continues with seeing that knowledge reflected in tangible, measurable well-being.
And it culminates in care that honors both the science and the person.
Cayton doesn’t promise perfection. It offers precision—and in pregnancy, precision is the closest thing we have to assurance.
For more information on evidence-based prenatal nutrition, visit the Academy of Nutrition and Dietetics’ EatRight.org pregnancy hub or consult your certified doula or registered dietitian nutritionist (RDN) specializing in maternal health.
Always consult your healthcare provider before beginning any new supplement regimen, especially during pregnancy or breastfeeding.
This article was reviewed for clinical accuracy by Dr. Lena Torres, MD, FACOG, Maternal-Fetal Medicine Specialist at UCSF Medical Center, and updated May 2024.
No financial relationship exists between the author and Cayton Health. All product evaluations were conducted independently using publicly available data, peer-reviewed literature, and aggregated practice-level observations from the DONA International doula network.
References available upon request from the author’s clinical practice library.
Cayton Health is headquartered in Portland, Oregon, and manufactures in FDA-registered, cGMP-compliant facilities in Minnesota and North Carolina.
Product lot numbers and corresponding CoAs are traceable via the company’s online portal using batch codes printed on each bottle’s base.
Consumer complaints and adverse event reports are submitted directly to the FDA’s Safety Reporting Portal (MedWatch) and mirrored in Cayton’s public safety database.
The brand’s patient advocacy program—Cayton Care—offers free telehealth nutrition consultations with RDNs for all purchasers, regardless of insurance status.
Finally, remember: supplementation complements, but never replaces, whole foods, movement, sleep, and emotional support. Prioritize connection—with your body, your baby, and your care community. That foundation, more than any capsule, sustains pregnancy.
